ARTICLE | Emerging Company Profile
Pneumagen: out-competing viral sugar binding to prevent infection
Pneumagen targeting infections, cancer by co-opting and enhancing microbial carbohydrate binders
February 13, 2020 11:42 PM UTC
With its platform of carbohydrate-binding proteins, Pneumagen is co-opting a pathogenic tool for interacting with host cells to block infections and adapting the technology for use against cancer.
Both viruses and bacteria can interact with human cells via proteins that recognize sugar residues, including sialic acid, on proteoglycans...
BCIQ Company Profiles